Swiss specialty chemicals group Clariant has posted net profit of SFr251 million ($274 million) for 2011, an increase of 31.4 per cent on the previous year.
This content was published on
1 minute
swissinfo.ch
Clariant, based at Muttenz near Basel, saw an increase in turnover of four per cent to SFr7.37 billion; the increase was 16 per cent in local currencies.
The group, which snapped up its German rival Süd-Chemie last year, reported that the two new Süd-Chemie business units had performed above target in the first eight months of consolidation.
Since December 1 2011 Süd-Chemie has been 100 per cent owned by Clariant and organised according to the Clariant operating model.
“Due to the acquisition of Süd-Chemie and the strength of the [Süd-Chemie] business unit catalysis & energy in the third and fourth quarters, sales were higher in the second half-year than in the first six months, despite a significant slowdown in some businesses towards year-end,” Clariant said.
Looking ahead to this year, Clariant said an accurate forecast was difficult given the current level of economic uncertainty. “Raw material costs are expected to rise in the mid-single-digit range while exchange rates should remain stable compared to the beginning of the year.”
Popular Stories
More
Swiss Abroad
An eye-opening guide to Switzerland’s ear-splitting sirens
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Pharma-chemical lobby demands unhindered trade
This content was published on
The sector’s lobby group said customs duties, red tape and patent abuses are draining funds away from vital research. But it insists a price-inflating ban on parallel imports should stay in place. A study commissioned by the Association of the Swiss Chemical and Pharmaceutical Companies showed the sector dominating the Swiss export market. Pharmaceutical and…
This content was published on
But while global competitors have experienced the same difficulties, the Basel-based duo have also been stung by the strong Swiss franc and strategic problems, according to analysts. Both companies operate in a competitive market producing chemicals, such as dyes and pigments, for the car, plastics, paper, construction and textile industries. Ciba shares plummeted on Tuesday…
This content was published on
But because of the firm’s deep restructuring programme, it posted a loss of SFr78 million when all operations – current and discontinued – are taken into account. Clariant saw sales rise for the year to SFr8.1 billion, with 7 per cent growth in Swiss francs. Overall, selling prices remained stable. “We achieved robust top-line growth…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.